Lantheus Holdings, Inc. (NASDAQ: LNTH) was downgraded by Truist to Hold from Buy, with a price target of $63 from $111 on August 11. The company sees quarter-over-quarter and year-over-year deceleration for at least another two quarters and potential uncertainty related to Pylarify trends.

Despite recognizing the long-term pipeline value, Lantheus Holdings, Inc. (NASDAQ: LNTH) may experience a period of stagnation for the next six months until there is clarity on the performance of Pylarify. The company focuses on diagnostic imaging and nuclear medicine products to support healthcare professionals in patient management and detection of cardiovascular disease.

Investors looking for undervalued AI stocks may find better opportunities than Lantheus Holdings, Inc. (NASDAQ: LNTH). The company’s potential may be outweighed by other AI stocks with higher upside potential and lower downside risk. For more information on AI stocks, readers can refer to a free report on the best short-term AI stock.

Read more at Yahoo Finance: Lantheus Holdings (LNTH) Gets Downgraded to Hold from Buy by Truist